YBX1 and breast carcinoma: STEMVAC is a DNA plasmid-based vaccine (STEMVAC) encoding Th1 selective epitopes from five antigens associated with breast cancer stem cells (MDM2, YB1, SOX2, CDC25B, CD105) which may be beneficial in helping the body to build an effective immune response to kill tumor cells.